MRF-Logo2019-Horizontal-RGB
May predict response to Ipi.
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

May predict response to Ipi.

› Forums › General Melanoma Community › May predict response to Ipi.

  • Post
Viewing 2 reply threads
  • Replies
      • February 11, 2014 at 2:53 pm
      POW
      Participant

        I seem to recall that somebody (probably Jerry) recently posted the abstract for this article.  However, this news report is written  better and is easier to understand. Thank you for posting it. 

        Dr. Hodi is currently overseeing a clinical trial combining MPDL3280A (an anti-PDL1 from Roche) with either Avastin (bevacizumab) or with one a several chemotherapy drugs. If you are interested, You can view the trial details at: http://www.clinicaltrials.gov/ct2/show/study/NCT01633970

        • February 11, 2014 at 2:53 pm
        POW
        Participant

          I seem to recall that somebody (probably Jerry) recently posted the abstract for this article.  However, this news report is written  better and is easier to understand. Thank you for posting it. 

          Dr. Hodi is currently overseeing a clinical trial combining MPDL3280A (an anti-PDL1 from Roche) with either Avastin (bevacizumab) or with one a several chemotherapy drugs. If you are interested, You can view the trial details at: http://www.clinicaltrials.gov/ct2/show/study/NCT01633970

          • February 11, 2014 at 2:53 pm
          POW
          Participant

            I seem to recall that somebody (probably Jerry) recently posted the abstract for this article.  However, this news report is written  better and is easier to understand. Thank you for posting it. 

            Dr. Hodi is currently overseeing a clinical trial combining MPDL3280A (an anti-PDL1 from Roche) with either Avastin (bevacizumab) or with one a several chemotherapy drugs. If you are interested, You can view the trial details at: http://www.clinicaltrials.gov/ct2/show/study/NCT01633970

        Viewing 2 reply threads
        • You must be logged in to reply to this topic.
        About the MRF Patient Forum

        The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

        The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

        Popular Topics